Hematology/Oncology and Stem Cell Therapy
Volume • Issue
- ISSN: 1658-3876
Editor-In-Chief: Mahmoud Aljurf
As of 2022 the journal has been transferred to the society. Visit the new homepage at Hemat… Read more
Subscription options
Institutional subscription on ScienceDirect
Request a sales quoteAs of 2022 the journal has been transferred to the society. Visit the new homepage at Hematology/Oncology and Stem Cell Therapy King Faisal Specialist Hospital & Research Center hosct.org.
Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors. The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles and special communications. It also offers a special section for clinically relevant images that provide an important educational value.
- ISSN: 1658-3876